LIFECORE BIOMEDICAL, INC. Other than Temporary Impairment Losses, Investments
LIFECORE BIOMEDICAL, INC. (LFCR) reported Other than Temporary Impairment Losses, Investments of $1.00 million for the 3-month period ending 2012-08-26, per its 10-Q/A filed 2013-01-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2013-01-02
- LIFECORE BIOMEDICAL, INC. other than temporary impairment losses, investments for the quarter ending 2012-08-26 was $1.00M.
| Period end | Other than Temporary Impairment Losses, Investments 3 month |
|---|---|
| 2012-08-26 | $1.00M 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |